Biofrontera Inc.
BFRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,988 | $9,030 | $8,588 | $12,559 |
| % Growth | -22.6% | 5.1% | -31.6% | – |
| Cost of Goods Sold | $1,922 | $2,380 | $3,075 | $5,272 |
| Gross Profit | $5,066 | $6,650 | $5,513 | $7,287 |
| % Margin | 72.5% | 73.6% | 64.2% | 58% |
| R&D Expenses | $854 | $870 | $1,207 | $783 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10,047 | $10,528 | $8,653 | $8,216 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $443 | $331 | $200 | $0 |
| Operating Expenses | $11,344 | $11,729 | $10,060 | $8,999 |
| Operating Income | -$6,278 | -$5,079 | -$4,547 | -$1,712 |
| % Margin | -89.8% | -56.2% | -52.9% | -13.6% |
| Other Income/Exp. Net | -$365 | -$224 | $343 | $313 |
| Pre-Tax Income | -$6,643 | -$5,303 | -$4,204 | -$1,399 |
| Tax Expense | $6 | $21 | -$1 | -$3 |
| Net Income | -$6,649 | -$5,324 | -$4,203 | -$1,396 |
| % Margin | -95.1% | -59% | -48.9% | -11.1% |
| EPS | -0.62 | -0.57 | -0.76 | 2.97 |
| % Growth | -8.8% | 25% | -125.6% | – |
| EPS Diluted | -0.62 | -0.57 | -0.76 | 2.97 |
| Weighted Avg Shares Out | 10,777 | 9,352 | 5,516 | 5,516 |
| Weighted Avg Shares Out Dil | 10,777 | 9,352 | 5,516 | 5,516 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $14 | $15 |
| Interest Expense | $111 | $115 | $120 | $55 |
| Depreciation & Amortization | $199 | $222 | $219 | $221 |
| EBITDA | -$6,333 | -$4,966 | -$3,865 | -$1,123 |
| % Margin | -90.6% | -55% | -45% | -8.9% |